Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used in the treatment of patients with type 2 diabetes and have proven protective effects on diabetic kidney disease (DKD). Whether DPP-4 inhibitors have renoprotective effects on insulin-deficient type 1 diabetes has not been comprehe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Gwon-Soo, Jeon, Jae-Han, Choe, Mi Sun, Kim, Sung-Woo, Lee, In-Kyu, Kim, Mi-Kyung, Park, Keun-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929225/
https://www.ncbi.nlm.nih.gov/pubmed/27098503
http://dx.doi.org/10.4093/dmj.2016.40.3.211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929225/
https://www.ncbi.nlm.nih.gov/pubmed/27098503
http://dx.doi.org/10.4093/dmj.2016.40.3.211

Ejemplares similares